Redx Pharma PLC (LSE:REDX) - Share price


Stock Report

Redx Pharma PLC REDX

Last Price
GBX5.35

Day Change
0.00|0.00%

As of 26/06/2019
14:25:29 BST | GBX
Minimum 15 Minutes Delay.

Last Close5.35p
Day Range5.20 - 5.47
Mkt Cap6.77Mil
52-Wk Range4.75 - 11.40
Yield %-
ISINGB00BSNB6S51
Volume58,335
P/E-0.84
P/S0.52
P/CF0.00

Share Price

Total Returns 25/06/2019

 Chg (%)  
More ...
Redx Pharma PLC1.90 
FTSE 100 TR GBP2.26
 
Financials
201620172018
More ...
Income Statement
Turnover0.0030.470.13
Operating Profit-14.3913.38-9.20
Net Profit-15.521.53-8.85
Reported EPS-19.801.40-7.00
Balance Sheet
Current Assets7.9527.049.71
Non Current Assets1.450.650.61
Total Assets9.4027.6910.32
Current Liabilities7.6813.363.95
Total Liabilities---
Total Equity1.7214.335.76
Cash Flow
Operating Cash Flow-13.2614.10-17.90
Net Change in Cash-3.6818.05-17.34

Company Profile

Redx Pharma PLC is principally engaged in drug discovery, pre-clinical development and licensing. It has an established portfolio of proprietary drug programs that it is developing alone and in partnership with pharmaceutical companies.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 19/11/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-159.29
Op Mrgn-71.31
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanMr. Iain Gladstone Ross
Non-Executive DirectorPeter Eric Presland LLB,ACA,FInstD
Non-Executive DirectorDr. Bernhard Jurgen Kirschbaum
Executive Director, Chief Executive OfficerMs. Lisa Mary Whewell Anson
Executive Director, Chief Financial OfficerDr. James Robert Mead
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.